HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- (N(2)- (3,4- dibromo- N- ((4- (3,4- dihydro- 2(1H)- oxoquinazolin- 3- yl)- 1- piperidinyl)carbonyl)tyrosyl)lysyl)- 4- (4- pyridinyl)piperazine

in clinical trials for treating acute migraine; structure in first source
Also Known As:
BIBN 4096; BIBN-4096; BIBN4096
Networked: 15 relevant articles (2 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Goadsby, Peter J: 2 articles (02/2012 - 03/2004)
2. Farinelli, Ivano: 2 articles (10/2009 - 09/2008)
3. Martelletti, Paolo: 2 articles (10/2009 - 09/2008)
4. Missori, Serena: 2 articles (10/2009 - 09/2008)
5. Roth, Willy: 2 articles (01/2006 - 07/2004)
6. Trocóniz, Iñaki F: 2 articles (01/2006 - 07/2004)
7. Wolters, Jan-Markus: 2 articles (01/2006 - 07/2004)
8. Chen, Lipeng: 1 article (01/2022)
9. Gao, Zhengdong: 1 article (01/2022)
10. Jiang, Xuewen: 1 article (01/2022)

Related Diseases

1. Migraine Disorders (Migraine)
2. Sclerosis
3. Acute Pain
4. Paresthesia (Dysesthesia)
5. Infections

Related Drugs and Biologics

1. olcegepant
2. Calcitonin Gene-Related Peptide Receptor Antagonists
3. Calcitonin Gene-Related Peptide
4. 2- (8- (3,5- difluorophenyl)- 10- oxo- 6,9- diazaspiro(4.5)dec- 9- yl)- N- (2'- oxo- 1,1',2',3- tetrahydrospiro(indene- 2,3'- pyrrolo(2,3- b)pyridin)- 5- yl)acetamide
5. telcagepant
6. Peptide Receptors (Peptide Receptor)
7. Calcitonin (Calcitonin, Eel)
8. Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
9. Type A Botulinum Toxins (Botox)
10. Vasoconstrictor Agents